Australia markets open in 3 hours 3 minutes
  • ALL ORDS

    6,168.00
    -93.80 (-1.50%)
     
  • AUD/USD

    0.7040
    -0.0009 (-0.13%)
     
  • ASX 200

    5,960.30
    -97.40 (-1.61%)
     
  • OIL

    36.40
    -0.99 (-2.65%)
     
  • GOLD

    1,869.80
    -9.40 (-0.50%)
     
  • BTC-AUD

    19,236.32
    +39.60 (+0.21%)
     
  • CMC Crypto 200

    265.95
    +23.27 (+9.59%)
     

J&J signs manufacturing deal with GRAM for potential COVID-19 vaccine

·1-min read

Sept 25 (Reuters) - Johnson & Johnson has signed a manufacturing deal for its coronavirus vaccine candidate with Grand River Aseptic Manufacturing Inc, the contract manufacturing organization said on Friday.

Michigan-based GRAM will manufacture the healthcare conglomerate's SARS-CoV-2 vaccine candidate, which is being developed with part funding from the U.S. government, and provide finished vials.

Earlier in the week, J&J launched a late-stage trial of its experimental single-shot COVID-19 vaccine and said its expects results of the trial by year end or early next year.

J&J, which is readying its supply chain to start distribution as soon as it gets FDA's approval, expects to manufacture as many as 1 billion doses in 2021. (Reporting By Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli)